D-0656-2025 Class II Ongoing
FDA drug recall D-0656-2025 was initiated by Zydus Pharmaceuticals (USA) Inc on Sep 4, 2025 and is designated Class II. Reason for recall: Failed Impurity/Degradation Specifications The recall status is ongoing. Affected quantity: 4344 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Sep 24, 2025
- Initiation Date
- Sep 4, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 4344 bottles
Product description
Entecavir Tablets, USP, 0.5 mg, 30 Tablets, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-920-06.
Reason for recall
Failed Impurity/Degradation Specifications
Distribution pattern
U.S. Nationwide
Code information
Lot E309376; Exp 11/30/2025
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0656-2025
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026